US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 2.650
  • -0.040-1.49%
Close Nov 29 13:00 ET
  • 2.790
  • +0.140+5.28%
Post 17:01 ET
218.52MMarket Cap-1709P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-49.66%8.52M
146.89%25.71M
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
Operating revenue
-49.66%8.52M
146.89%25.71M
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
Cost of revenue
Gross profit
Operating expense
25.44%76.44M
31.45%74.39M
26.75%69.6M
23.53%243.01M
21.98%70.57M
31.45%60.94M
19.20%56.59M
21.95%54.91M
22.64%196.72M
26.62%57.85M
Selling and administrative expenses
-6.14%14.33M
-17.52%12.37M
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-General and administrative expense
-6.14%14.33M
-17.52%12.37M
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
Research and development costs
36.00%62.11M
49.12%62.02M
44.36%56.88M
31.53%180.43M
24.64%53.77M
44.00%45.67M
28.64%41.59M
31.37%39.4M
31.39%137.17M
44.13%43.14M
Operating profit
-54.31%-67.92M
-5.43%-48.69M
-33.98%-56.59M
30.76%-89.28M
187.67%43.15M
-107.52%-44.01M
-138.29%-46.18M
-7.93%-42.24M
-30.87%-128.94M
-40.49%-49.22M
Net non-operating interest income expense
563.81%19.13M
-702.52%-4.13M
-1,144.37%-5.3M
-8,577.06%-9.24M
-247.96%-4.17M
-132.53%-4.13M
-29.72%-515K
21.26%-426K
104.26%109K
646.71%2.82M
Non-operating interest income
494.33%27.04M
72.80%4.91M
60.00%4.1M
319.97%14.51M
114.19%4.56M
348.72%4.55M
1,342.64%2.84M
2,106.90%2.56M
498.79%3.46M
2,116.67%2.13M
Non-operating interest expense
-8.82%7.91M
169.41%9.04M
214.70%9.4M
609.80%23.75M
1,360.03%8.73M
211.15%8.68M
465.15%3.36M
354.49%2.99M
6.66%3.35M
-213.24%-693K
Other net income (expense)
-42.22%4.81M
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
Gain on sale of security
----
-42.22%4.81M
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
Income before tax
-2.83%-48.79M
-25.11%-48.01M
-17.23%-58.21M
24.08%-88.6M
235.49%46.87M
-143.46%-47.45M
-63.21%-38.37M
-26.96%-49.66M
-10.58%-116.7M
9.26%-34.59M
Income tax
0
-94.70%8K
0
627.68%18.19M
15.81M
1.84M
-93.96%151K
395K
2.5M
0
Net income
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
Net income continuous Operations
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
Minority interest income
Net income attributable to the parent company
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
Basic earnings per share
27.16%-0.59
7.81%-0.59
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
Diluted earnings per share
27.16%-0.59
7.81%-0.59
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -49.66%8.52M146.89%25.71M2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M
Operating revenue -49.66%8.52M146.89%25.71M2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M
Cost of revenue
Gross profit
Operating expense 25.44%76.44M31.45%74.39M26.75%69.6M23.53%243.01M21.98%70.57M31.45%60.94M19.20%56.59M21.95%54.91M22.64%196.72M26.62%57.85M
Selling and administrative expenses -6.14%14.33M-17.52%12.37M-17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M
-General and administrative expense -6.14%14.33M-17.52%12.37M-17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M
Research and development costs 36.00%62.11M49.12%62.02M44.36%56.88M31.53%180.43M24.64%53.77M44.00%45.67M28.64%41.59M31.37%39.4M31.39%137.17M44.13%43.14M
Operating profit -54.31%-67.92M-5.43%-48.69M-33.98%-56.59M30.76%-89.28M187.67%43.15M-107.52%-44.01M-138.29%-46.18M-7.93%-42.24M-30.87%-128.94M-40.49%-49.22M
Net non-operating interest income expense 563.81%19.13M-702.52%-4.13M-1,144.37%-5.3M-8,577.06%-9.24M-247.96%-4.17M-132.53%-4.13M-29.72%-515K21.26%-426K104.26%109K646.71%2.82M
Non-operating interest income 494.33%27.04M72.80%4.91M60.00%4.1M319.97%14.51M114.19%4.56M348.72%4.55M1,342.64%2.84M2,106.90%2.56M498.79%3.46M2,116.67%2.13M
Non-operating interest expense -8.82%7.91M169.41%9.04M214.70%9.4M609.80%23.75M1,360.03%8.73M211.15%8.68M465.15%3.36M354.49%2.99M6.66%3.35M-213.24%-693K
Other net income (expense) -42.22%4.81M152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M
Gain on sale of security -----42.22%4.81M152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M
Income before tax -2.83%-48.79M-25.11%-48.01M-17.23%-58.21M24.08%-88.6M235.49%46.87M-143.46%-47.45M-63.21%-38.37M-26.96%-49.66M-10.58%-116.7M9.26%-34.59M
Income tax 0-94.70%8K0627.68%18.19M15.81M1.84M-93.96%151K395K2.5M0
Net income 1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M
Net income continuous Operations 1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M
Minority interest income
Net income attributable to the parent company 1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M
Basic earnings per share 27.16%-0.597.81%-0.59-11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.61
Diluted earnings per share 27.16%-0.597.81%-0.59-11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data